{
    "Trade/Device Name(s)": [
        "HCY POC Test",
        "HCY POC Assay",
        "Diazyme Homocysteine POC Test",
        "Diazyme Homocysteine POC Test Kit"
    ],
    "Submitter Information": "Diazyme Laboratories",
    "510(k) Number": "K121053",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071971"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LPS"
    ],
    "Summary Letter Date": "July 11, 2012",
    "Summary Letter Received Date": "July 13, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1377"
    ],
    "Regulation Name(s)": [
        "Urinary Homocysteine (non-quantitative) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total L-homocysteine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Lithium Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "SMART Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme cycling method",
        "Spectrophotometric detection"
    ],
    "Methodologies": [
        "Enzymatic cycling assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Control",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Diazyme HCY POC Test Kit using enzymatic cycling assay for quantitative determination of total L-homocysteine in serum or plasma on SMART Analyzer",
    "Indications for Use Summary": "Intended for use with SMART analyzer in point-of-care settings for in vitro quantitative determination of total L-homocysteine in serum or plasma to assist in diagnosis and treatment of patients suspected of hyperhomocysteinemia and homocystinuria",
    "fda_folder": "Clinical Chemistry"
}